Bristol Myers CEO Caforio hires a top investment banker from Barclays for his next BD/strategy chief
Giovanni Caforio has a new right-hand woman to lead up the next round of M&A and BD deals at Bristol Myers Squibb. And Paul Biondi’s replacement will have no trouble navigating the banking world in her new post.
Elizabeth Mily gets the seat on the executive committee that belongs to the chief of the strategy and business development group. Mily is jumping over from Barclays, where she chaired the global life sciences group.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 84,700+ biopharma pros reading Endpoints daily — and it's free.